目的制备枸橼酸钾缓释片并考查其体外释放机制。
ObjectiveTo prepare potassium citrate sustained-release tablets and study its in-vitro release mechanism.
方法通过测定枸橼酸钾和钙离子络合后的钙离子含量，间接测定枸橼酸钾含量。
METHOD Indirect content determined of potassium citrate solution by determined content of calcium ion after complex reaction between potassium citrate and calcium chloride.
考虑到实验的学术价值和经济价值，最终选定枸橼酸钾作为本实验的模型药物。
Potassium citrate was chosen as the model drug considering its academic and economic value .
考虑到实验的学术价值和经济价值，最终选定枸橼酸钾作为本实验的模型药物。
Potassium citrate was chosen as the model drug considering its academic and economic value.
与服用氯化钾的女性相比，服用枸橼酸钾的女性的脊骨及髋骨表现骨矿物质密度明显升高。
The women taking potassium citrate showed significant increases in BMD at the spine and hip compared with the women given potassium chloride.
与服用氯化钾的女性相比，服用枸橼酸钾的女性的脊骨及髋骨表现骨矿物质密度明显升高。
The women taking potassium citrate showed significant increases in BMD at the spine and hip compared with the women given potassium chloride.
应用推荐